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Abstract
Background: Cerebrotendinous xanthomatosis is a very rare autosomal recessive lipid storage disorder affecting
bile acid biosynthesis. It is manifested by subtle neurological and non-neurological symptoms due to abnormal
tissue lipid deposition. Diagnosis is usually delayed but early diagnosis and replacement therapy can prevent
devastating neurological sequelae.
Case presentation: We present a case of a 25-year-old Asian Indian woman who presented with gait difficulty,
fusiform swellings of bilateral tendo-Achilles and infrapatellar tendons, along with history of bilateral cataract
surgery 1 year earlier. The diagnosis was made on the basis of clinical, biochemical, imaging, and histopathological
analysis and replacement therapy was started.
Conclusions: The peculiarity of the present case is the absence of any neurological manifestations which are
usually the early clues to the diagnosis of cerebrotendinous xanthomatosis. The present case report emphasizes
the fact that early age bilateral cataracts along with bilateral tendo-Achilles xanthomas can be early pointers toward
the diagnosis of cerebrotendinous xanthomatosis.
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Background
Cerebrotendinous xanthomatosis (CTX) is a rare autosomal
recessive lipid disorder: phenotype Online Mendelian
Inheritance in Man (OMIM)#213700, gene OMIM#606530
[1]. It is caused by mutations in gene CYP27A1 located on
the chromosome 2q33-qter causing lack of enzyme
mitochondrial sterol 27-hydroxylase [1]. CYP27A1
plays a pivotal role in cholesterol side chain oxidation
during the synthesis of chenodeoxycholic acid (CDCA)
which is a bile acid [2]. Therefore perturbations in
CYP27A1 gene result in reduced enzymatic activity caus-
ing impairment of cholesterol side chain oxidation finally
culminating in excessive production and abnormal depos-
ition of cholestanol in various tissues [1, 2]. The classical
triad of the syndrome consists of premature bilateral
cataract, tendon xanthomas (predominantly involving
tendo-Achilles) and various neurological abnormalities
[3]. A recent study by Appadurai et al. [2] stated that in
the absence of epidemiological studies the disease is
considered to be exceedingly rare but it is actually under-
reported. This group studied the Exome Aggregation Con-
sortium (ExAC) cohort of 60,000 unrelated adults globally
for the frequency of 57 reported pathogenic variants of
CYP27A1 along with 29 additional variants through bio-
informatics; they estimated that the incidence of CTX
ranged from 1:134,970 to 1:461,358 in Europe, 1:263,222
to 1:468,624 in Africa, 1:71,677 to 1:148,914 in the USA,
1:64,267 to 1:64,712 in East Asia, and 1:36,072 to
1:468,624 in South Asia [2]. However, another recent
study by Ragno et al. stated that more than 300 cases have
been reported so far with approximately 50 mutations
with little correlation between genotype and phenotype
[4]. The mean age of onset of the symptoms is 19 years
while the mean age at diagnosis is 35 years representing a
lag of 16 years in the diagnosis [5]. A recent study of
19 patients from 15 unrelated Italian families by Mignarri
et al. estimated the median age at diagnosis to be 32 years* Correspondence: syedrazi1983@gmail.com
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while the mean age was 32.5±10.4 years [6]. Replacement
therapy with CDCA delays or even reverses the progres-
sion of the disease [3]; however, because there is a lag
period between the onset of symptoms and the mean age
of diagnosis [1], early diagnosis is required to prevent dev-
astating neurological sequelae and other complications
such as premature atherosclerosis and osteoporosis.
So a high index of suspicion should be kept in any
patient encountered with the classical triad as illus-
trated in the present case report.
Case presentation
A 25-year-old Asian Indian woman presented with com-
plaints of swellings behind both her ankles and in front
of both her knees for the last 2 years. These swellings
had an insidious onset; they were painless, gradually pro-
gressive, and caused difficulty in walking for the last
1 year. She had history of bilateral cataract surgery 1 year
earlier. There was no history of childhood diarrhea, sei-
zures, cerebellar symptoms, psychiatric manifestations,
mental retardation, or premature atherosclerosis. There
was no family history of similar complaints.
On examination, she had firm, non-tender, fusiform
swellings over bilateral tendo-Achilles (right 10×4.5 cm,
left 8×3 cm) and bilateral infrapatellar tendons (right
2×1.5 cm, left 1.5×1.2 cm) as shown in Fig. 1a, b. Her
general examination was unremarkable except for bilat-
eral pseudophakic eyes. On neurological examination,
her higher mental functions were normal. Her pupils
were normal sized and normally reactive. Her sensory
system was unremarkable. Her muscle bulk, tone, power,
coordination, and other motor system functions were
normal. All her cranial nerves were normal. Her cardiac,
abdominal and respiratory examinations were also
unremarkable.
Her hemogram, renal function test, hepatic function
test, serum electrolytes, and fasting lipid profile were
within the normal limits. Her serum cholestanol level
was 4.27 mg/dl (normal value 0.02 to 0.12 mg/dl). Serum
and urinary bile alcohol could not be done because
of unavailability. Electrocardiography, two-dimensional
echocardiography, spirometry, and nerve conduction
study were unremarkable. X-rays of both her legs re-
vealed soft tissue thickening in bilateral ankles poster-
iorly and overlying right tibial tuberosity as shown in
Fig. 2. Ultrasonography of bilateral tendo-Achilles re-
vealed anteroposterior thickness of 7.5 mm and loss
of normal tendon appearance with multiple hypoe-
choic foci within the tendon as shown in Fig. 3. Mag-
netic resonance imaging (MRI) of her brain revealed
T2 and fluid-attenuated inversion recovery (FLAIR)
hyperintense signals in the region of the dentate nu-
cleus of both her cerebellar hemispheres with high
choline and low N-acetylaspartate (NAA)/creatine
peaks on magnetic resonance spectroscopy (MRS) as
shown in Fig. 4a, b. She underwent excisional biopsy
of her right infrapatellar which yielded a gray, brown,
soft tissue measuring 2×2×1 cm on gross examination
as shown in Fig. 5a. Microscopic examination revealed
foamy cells admixed with inflammatory cells and giant
cells surrounding cholesterol clefts as shown in Fig. 5b.
On the basis of these findings the diagnosis of CTX was
made and she was started on replacement with CDCA
250 mg three times a day, ursodeoxycholic acid 300 mg
three times a day, and atorvastatin 10 mg at bedtime.
Discussion
CTX is a rare autosomal recessive inborn error of bile
acid synthesis first reported by Von Bogaert in 1937.
The disease is caused by mutation in gene CYP27A1
Fig. 1 a Bilateral fusiform tendo-Achilles xanthomas: right 10×4.5 cm, left 8×3 cm. b Bilateral infrapatellar tendon xanthomas: right 2×1.5 cm,
left 1.5×1.2 cm
Razi et al. Journal of Medical Case Reports  (2016) 10:103 Page 2 of 5
located on chromosome 2q33-qter leading to a lack of
mitochondrial sterol 27-hydroxylase enzyme at the inner
mitochondrial membrane in almost all cells of the body
[7, 8]. Absence of sterol 27-hydroxylase enzyme activity
causes deficiency of CDCA and cholic acid leading to a
loss of feedback inhibition of rate-limiting enzyme choles-
terol 7α-hydroxylase (CYP7A1) of bile synthesis, which
results in excess production of cholestanol which gets
deposited in various tissues [1–3].
The diagnosis is delayed due to subtle manifesta-
tions and the rarity of the disease [1]. The disease
has multiorgan involvement such as bilateral prema-
ture cataracts, intractable childhood diarrhea, tendon
xanthomas, neurological abnormalities, and premature
atherosclerosis. The usual manifestations are due to
deposition of excess cholestanol and cholesterol in
the affected tissues [1, 3]. Our patient presented with
bilateral tendo-Achilles tuberous xanthomas along
with premature bilateral cataracts but no neurological
abnormalities.
Familial hypercholesterolemia and sitosterolemia are
the two important differential diagnoses of CTX. CTX is
differentiated clinically from other disorders of lipid metab-
olism because of juvenile cataracts, progressive neurological
symptoms, mild pulmonary insufficiency, and increased
levels of cholestanol [9]. In the absence of tendinous xan-
thomas, CTX may be confused with Marinesco–Sjögren
syndrome as it also presents with early age cataracts,
cerebellar ataxia, neuromuscular weakness, and men-
tal retardation but it can be differentiated from CTX
by short stature, skeletal anomalies and hypergonado-
tropic hypogonadism [10, 11].
The laboratory findings include a normal or reduced
serum cholesterol level, increased serum cholestanol, in-
creased 7α-hydroxy-4-cholesten-3-one (7αC4), increased
lathosterol, increased plant sterols (campesterol, sitos-
terol), increased serum and urinary bile acid alcohols
but reduced serum CDCA and 27-hydroxycholesterol
(27-OHC) [6]. Typical MRI findings are bilateral T2
and FLAIR hyperintense, nonhomogeneous signals in
dentate nuclei and surrounding cerebellum. There are
diffuse or focal white matter abnormalities along with
cerebral and cerebellar atrophy [1, 3, 10]. MRS stud-
ies reveal increased lactate and lipid peaks in FLAIR
sequence-hypointense lesions, and diffusely decreased
NAA peaks. Microscopy reveals foamy cells admixed
with inflammatory cells and giant cells surrounding
cholesterol clefts [1]. These laboratory findings exactly
correlate with those of our patient in the present
discussion.
The treatment consists of replacement therapy, sur-
gery and other symptomatic therapies. The replacement
therapy can prevent or even reverse neurological
Fig. 3 Ultrasonography of tendo-Achilles showing anteroposterior
thickness of 7.5 mm with loss of normal tendon appearance and
multiple hypoechoic foci within tendon
Fig. 2 X-ray showing soft tissue thickening of bilateral tendo-Achilles
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complications and involves administration of bile acids
such as CDCA, ursodeoxycholic acid, cholic acid, and
taurocholic acid. Among these, CDCA is considered the
drug of choice. Hydroxymethylglutaryl-CoA (HMG-CoA)
synthase inhibitors are considered to enhance the ef-
fect of replacement therapy. Surgery may deteriorate
gait imbalance and does not prevent neurological compli-
cations [1].
Conclusions
CTX is a rare and underreported lipid storage disorder.
Although it is medically manageable, a delay in diagnosis
can be devastating for the patient so early diagnosis
based on a high index of suspicion is imperative for bet-
ter management.
Consent
Written informed consent was obtained from the pa-
tient for publication of this case report and any ac-
companying images. A copy of the written consent is
available for review by the Editor-in-Chief of this
journal.
Fig. 5 a Gross – excisional biopsy specimen from right infrapatellar tendon xanthomas measuring 2×2×1 cm with gray, brown, soft tissue.
b Microscopic analysis – showing foamy cells admixed with inflammatory cells and giant cells surrounding cholesterol clefts
Fig. 4 a Brain magnetic resonance imaging T2 sequence showing hyperintensities in bilateral dentate nuclei. b Magnetic resonance spectroscopy
showing high choline and low N-acetylaspartate/creatine peaks
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